drugset / Trial / NCT02576223

Suprascapular Nerve Block as Postoperative Analgesia After Artroscopic Shoulder Surgery

NCT02576223 ↗

Completed 40 enrolled Kai Henrik Wiborg Lange
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this randomized study is to examine the effect of a selective suprascapular nerve block on post operative pain after arthroscopic shoulder surgery. Half of the subjects will receive a active nerve block with Ropivacain. Half of the subjects will receive a placebo nerve block with saline.

Timeline

Start
2015-10
Primary completion
2018-08-27
Completion
2018-08-27

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ropivacaine Other / unclassified 5 ml Other
Comparator Ropivacaine Other / unclassified 7.5 mg/ml Other
Comparator Morphine Other / unclassified 2.5 mg Intravenous
Comparator Morphine Other / unclassified 5 mg Intravenous

Indications

No indication recorded.